Sanofi (SNY) EBT Margin (2009 - 2026)

Sanofi has disclosed EBT Margin across 18 years of filings, most recently posting 12.17% for Q2 2026.

• In Q2 2026, EBT Margin fell 504.0% year-over-year to 12.17%; the TTM figure through Jun 2026 stood at 16.87% (down 899.0% YoY), while the FY2025 annual figure was 14.15%, down 737.0% from the prior year.
• EBT Margin came in at 12.17% for Q2 2026 at Sanofi, down from 22.45% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 148.39% in Q4 2023 to a low of 12.17% in Q2 2026.
• Average EBT Margin over 5 years is 31.35%, with a median of 24.32% recorded in 2022.
• Year-over-year, EBT Margin jumped 12953 bps in 2023 and tumbled 12118 bps in 2024.
• Over 5 years, EBT Margin stood at 18.87% in 2022, then soared by 687 bps to 148.39% in 2023, then plunged by 82 bps to 27.21% in 2024, then jumped by 85 bps to 50.34% in 2025, then slumped by 76 bps to 12.17% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 12.17% in Q2 2026, 22.45% in Q1 2026, and 50.34% in Q4 2025.